Dose Confirmation Trial of AAV5-hFIXco-Padua

NCT03489291 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
3
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

CSL Behring